IDD Therapeutics (אי.די.די. תרפיוטיקס)

Nazareth, Israel

IDD Therapeutics Ltd. is a drug development company for cancer therapy. The IDD Therapeutics main focus is improving specificity, safety and efficacy of an existing non-specific cancer treatments and protocols. Our unique and novel proprietary discovery platform, Intelligent Learning Engine (ILE®) is being used to build up a diverse pipeline of products. ILE® powerful technology was employed to design targeted small molecule New Therapeutic Entity (NTE) for cancer therapy. Our main focus is improving specificity, safety and NTEs, with multifunctional Mechanism of Action towards specific biological targets in the tumor cells (ILE® molecular activity indexing). The first innovative compound is a targeted, multifunctional Mode of Action (MoA), NTE consisting of neuro-protective anti-oxidant moiety. IDD-1040 is a small molecule and synthesized in a one-step chemical procedure, demonstrating a unique PK, superior efficacy and safety. Additional drug candidates, IDD-1010 and IDD-2010, are being developed and currently at the early preclinical stage. IDD Therapeutics operates within New Generation Technology (NGT) incubator, funded by the Israeli Office of Chief Scientist and private capital.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out IDD Therapeutics (אי.די.די. תרפיוטיקס) on @MedStartr Today #SolidTumors #HematologicMalignancies #CancerOncology #Cancer #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/mbSwCDWOYHI

Get Involved in IDD Therapeutics (אי.די.די. תרפיוטיקס)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2012
Website: www.idd-therapeutics.com

Disease Areas

Solid Tumors Hematologic Malignancies Cancer & Oncology

Technologies

Drug DevelopmentTherapeuticsSmall Molecule DrugsPharmaceutical Innovation

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of IDD Therapeutics (אי.די.די. תרפיוטיקס)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.